Suchergebnisse - "Minami, Hironobu"

PubPharm (23)

11

TYRO3 as a potential therapeutic target in breast cancer

enthalten in: Anticancer research | 2014

von Ekyalongo, R. | Mukohara, T. | Funakoshi, Y. | +7

12

Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line

enthalten in: Investigational new drugs | 2013

von Funakoshi, Y. | Mukohara, T. | Tomioka, H. | +8

13

Hypothyroidism in patients with colorectal carcinoma treated with fluoropyrimidines

enthalten in: Oncology reports | 2013

von Fujiwara, Y. | Chayahara, N. | Mukohara, T. | +4

14

Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line

enthalten in: Investigational new drugs | 2013

von Ekyalongo, R. | Mukohara, T. | Kataoka, Y. | +5

15

Regulation of MET kinase inhibitor resistance by copy number of MET in gastric carcinoma cells

enthalten in: Oncology research | 2013

von Funakoshi, Y. | Mukohara, T. | Ekyalongo, R. | +8

16

Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification

enthalten in: International journal of oncology | 2012

von Tomioka, H. | Mukohara, T. | Kataoka, Y. | +6

17

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

enthalten in: Investigational new drugs | 2012

von Kataoka, Y. | Mukohara, T. | Tomioka, H. | +7

18

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure : results from phase I studies in Japanese patients

enthalten in: Investigational new drugs | 2012

von Fujiwara, Y. | Kiyota, N. | Chayahara, N. | +4

19

Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : a phase I study in Japanese patients

enthalten in: Cancer science | 2010

von Mukohara, T. | Nakajima, H. | Mukai, H. | +5

20

Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression

enthalten in: Cancer letters | 2009

von Mukohara, T. | Shimada, H. | Ogasawara, N. | +8